Aclara Research and the Mars Agency partnered to field a study across cannabis shoppers in legal markets to understand how acceptance of cannabis products shifts consumer behavior, their perception of cannabis retailers and the shopping experience in this new channel. Our extensive research with cannabis consumers suggests cannabis will be more disruptive to the consumer packaged goods industry than Uber has been to transportation!
In addition to our syndicated and custom research studies, Aclara Research independently funds patient and consumer studies to increase public understanding of the leading reasons for cannabis product usage (HINT: it’s not about getting high). See our recent studies across markets:
Aclara Research partnered with a group of pharmacist professionals active within the cannabis industry to understand how patient usage of medical cannabis has impacted prescription drug and opioid usage. The team partnered with patient advocacy groups and dispensaries to field a 41 question online survey across over 400 respondents in September 2017.
Aclara Research conducted the first study of Illinois patients since the inception of the medical cannabis pilot program. This study of nearly 300 respondents was the first, largest and most comprehensive study of the impact of medical cannabis on patient health and well-being within the market. This 74 question survey focused on the leading conditions and symptoms, product segment and brand purchases, perceived product efficacy and experience within the health care system.
Aclara Research has deep insight into the cannabis and CBD Consumer. We used their survey panel to discover key health and wellness behaviors that aligned with our portfolio.”
They helped us understand how and why consumers use cannabis and CBD products.
The Aclara team showed us the behavioral differences between our current cannabis shopper, and the new consumer entering our stores.